A mouse model, in which GR dimerization is impaired (GRdim), has allowed several laboratories to show that GR dimerization is also required for the anti-inflammatory properties of GCs in several contexts, such as rheumatoid arthritis (71, 72), septic shock (73, 74), or inflammatory bowel disease (75). This evidence concerns the gene NR3C1 and inflammatory bowel disease.